Alexandra Schiettekatte, Author at Biowin

Alexandra Schiettekatte In Life Science events

Webinar: Investor Perspective – The Strategic Venturing Spectrum

WEBINAR Investor Perspective: The Strategic Venturing Spectrum June 7, 2022 | Virtual 16:00 - 17:00 CEST ORGANIZED BY JOHNSON & JOHNSON INNOVATION Is your startup interested in access to Corporate Venture Capital (CVC)? You may be more successful in landing an investment if you learn to look from their...

Alexandra Schiettekatte In Blogs

ESG for Pharmaceuticals and Life Sciences (3)

SERIES on ESG in collaboration with PWC Why ESG is critical in IPO communications ? Discover more in PWC’s latest reports! You never get a second chance to make a first impression - Why ESG is critical in IPO communications - Companies looking to access capital via IPO's need to...

Alexandra Schiettekatte In Radiation applied to health

EANM – European Association of Nuclear Medicine 2022

Exhibition - EANM 2022 Congress Annual Congress of the European Association of Nuclear Medicine October 15 - 19, 2022, Barcelona, SPAIN AWEX Collective Pavilion _____________________________ The Walloon Export and Foreign Investment Agency (AWEX) will organize a collective participation in the 35th Annual Congress of the European Association of Nuclear Medicine...

Alexandra Schiettekatte In Life Science events, Partner events

HealthTech For Patients 2nd Edition

HealthTech For Patients 2nd Edition Thursday, May 19th 2022 - 1:00 PM (CEST) Digital event _____________________________________ HealthTech for Care invites you to attend 2nd edition of the HealthTech For Patients (HTFP) meeting on Thursday May 19, 2022 from 1pm to 4 pm CET virtually. This half-day session would present...

Alexandra Schiettekatte In Blogs

ESG for Pharmaceuticals and Life Sciences (1)

SERIES on ESG in collaboration with PWC How can health organizations integrate ESG priorities? Discover more in PWC's latest publications! PwC's Health Research Institute analysed ESG efforts of 32 pharmaceutical and life science companies and found that the sector could reap more rewards from embedding more of an environmental and...

Alexandra Schiettekatte In Life Science events, Partner events

RegMed Europe

Welcome to Regmed Europe The 2nd edition of the European Biomaterials & Regenerative Medicine Matchmaking event. When? 3rd of June from 9am to 5pm Where? Cité Universitaire in Paris Get the opportunity to discover more about Biomaterials, Regenerative Medicine, Regulatory challenges and learn from innovative European SMEs and clusters....

Alexandra Schiettekatte In Blogs

Why you should attend the Life On Chip conference

If you are curious to learn more about the latest cross-over innovations then you certainly have to attend the 4th Life-On-Chip Conference - Initiating Convergence in Health Technologies’ organised by Smart Hub Flemish Brabant and flanders.healthTech, BioWin, imec, Antleron, VIB and EIT Health. With more than 200 participants from Europe...

Alexandra Schiettekatte In Blogs

The “BioMan” project or the common ambition to accelerate and intensify the digitalization of bioprocesses in Wallonia

The "BioMan" project or the common ambition to accelerate and intensify the digitalization of bioprocesses in Wallonia BioWin, as coordinator, joins essenscia wallonie and CETIC in this "Industry of the Future" programme whose ambition is to reinforce Wallonia's position among the European leaders in biomanufacturing. What is the...

Alexandra Schiettekatte In BioWin events, Life Science events, Partner events

NuMed Connect – European Networking in Nuclear Medicine

NuMed Connect – European Networking in Nuclear Medicine | #1 Launching Webinar 3rd February 2022 From 10:00-12:00 The health clusters Atlanpole Biotherapies (France), BioWin (Belgium), Caen Normandie Développement (France) and Eurobiomed (France) will organise a cycle of events in nuclear medicine in 2022. The aim is to stimulate connexions...

Alexandra Schiettekatte In BioWin events, Life Science events

Virtual Workshop (BioWin-Catalent)

Advancing Manufacturing Faster for Next Generation hiPSC-Based Clinical Therapies January 27th, 2022 | Time: 16:00 CET Virtual Workshop (BioWin-Catalent) Human induced pluripotent stem cell (hiPSC)-based therapy is currently at the forefront of technology boom and is advancing at a rapid pace. Generating hiPSCs under current Good Manufacturing Practice (cGMP)...